Home Perinatal outcome in gestational diabetes according to different diagnostic criteria
Article
Licensed
Unlicensed Requires Authentication

Perinatal outcome in gestational diabetes according to different diagnostic criteria

  • Lina Salman ORCID logo EMAIL logo , Anat Pardo , Eyal Krispin , Galia Oron , Yoel Toledano and Eran Hadar ORCID logo
Published/Copyright: April 15, 2019

Abstract

Objectives

To evaluate whether gestational diabetes mellitus (GDM) diagnosed by different criteria impacts perinatal outcome.

Methods

This was a retrospective study of deliveries with a diagnosis of GDM (2014–2016). Perinatal outcomes were compared between patients with: (1) GDM diagnosed according to a single abnormal value on the 100-g oral glucose tolerance test (OGTT); (2) two or more abnormal OGTT values; and (3) a 50-g glucose challenge test (GCT) value ≥200 mg/dL.

Results

A total of 1163 women met the inclusion criteria, of whom 441 (37.9%) were diagnosed according to a single abnormal OGTT value, 627 (53.9%) had two or more abnormal OGTT values and 95 (8.17%) had a GCT value ≥200 mg/dL. Diet-only treatment was significantly higher in the single abnormal value group (70.3% vs. 65.1% vs. 50.5%) and rates of medical treatment were significantly higher in the GCT ≥ 200 mg/dL group (P < 0.05). Women in the GCT ≥ 200 mg/dL group had higher rates of neonatal intensive care unit (NICU) admission (10.5% vs. 2.7% vs. 2.8%, P < 0.001) and neonatal hypoglycemia (5.3% vs. 0.5% vs. 0.8%, P < 0.001). On multivariate logistic regression, GCT ≥ 200 mg/dL was no longer associated with higher rates of NICU admission and neonatal hypoglycemia (P > 0.05).

Conclusion

No difference was noted in the perinatal outcome amongst the different methods used for diagnosing GDM.


Corresponding author: Lina Salman, MD, Helen Schneider Hospital for Women, Rabin Medical Center, 4941492 Petach-Tikva, Israel; and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel, Tel.: +972-3-9377680, Fax: +972-3-9377683

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diab Rep 2016;16:1–11.10.1007/s11892-015-0699-xSearch in Google Scholar

2. American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care 2016;39:S13–22.10.2337/dc16-S005Search in Google Scholar

3. Jacobson JD, Cousins L. A population-based study of maternal and perinatal outcome in patients with gestational diabetes. Am J Obstet Gynecol 1989;161:981–6.10.1016/0002-9378(89)90767-9Search in Google Scholar

4. Vignoles P, Gire C, Mancini J, Bretelle F, Boubli L, Janky E, et al. Gestational diabetes: a strong independent risk factor for severe neonatal respiratory failure after 34 weeks. Arch Gynecol Obstet 2011;284:1099104.10.1007/s00404-010-1810-9Search in Google Scholar PubMed

5. Naylor CD, Sermer M, Chen E, Sykora K. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto Trihospital Gestational Diabetes Investigators. J Am Med Assoc 1996;275:1165–70.10.1001/jama.275.15.1165Search in Google Scholar

6. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352: 2477–86.10.1056/NEJMoa042973Search in Google Scholar PubMed

7. Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L. Diagnostic thresholds for gestational diabetes and their impact on pregnancy outcomes: a systematic review. Diabet Med 2014;31:319–31.10.1111/dme.12357Search in Google Scholar PubMed

8. American Diabetes Association. Standards of medical care in diabetes – 2012. Diabetes Care 2012;35(Suppl 1):S11–63.10.2337/dc12-s011Search in Google Scholar PubMed PubMed Central

9. McLaughlin GB, Cheng YW, Caughey AB. Women with one elevated 3-hour glucose tolerance test value: are they at risk for adverse perinatal outcomes? Am J Obstet Gynecol 2006;194: e16–9.10.1016/j.ajog.2006.01.028Search in Google Scholar PubMed

10. Roeckner JT, Sanchez-Ramos L, Jijon-Knupp R, Kaunitz AM. Single abnormal value on 3-hour oral glucose tolerance test during pregnancy is associated with adverse maternal and neonatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol 2016;215:287–97.10.1016/j.ajog.2016.04.040Search in Google Scholar PubMed

11. Ankumah NA, Tita ATN, Biggio JR, Harper LM. Pregnancy outcomes in women with 1-hour glucose challenge test ≥200 mg/dL. Am J Perinatol 2016;33:490–4.10.1055/s-0035-1566307Search in Google Scholar PubMed PubMed Central

12. Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES. Birthweight standards in the live-born population in Israel. Isr Med Assoc J 2005;7:311–4.Search in Google Scholar

13. Sunjaya AP, Sunjaya AF. Diabetes in pregnancy and infant mortality: link with glycemic control. Diabetes Metab Syndr Clin Res Rev 2018;43:837–9.10.1016/j.dsx.2018.06.019Search in Google Scholar PubMed

14. Lowe LP, Metzger BE, Dyer AR, Lowe J, McCane DR, Lappin TR, et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care 2012;35:574–80.10.2337/dc11-1687Search in Google Scholar PubMed PubMed Central

15. Langer O, Yogev Y, Most O, Xenakis EMJ. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 2005;192:989–97.10.3109/9781439802007.014Search in Google Scholar

16. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361: 1339–48.10.1056/NEJMoa0902430Search in Google Scholar PubMed PubMed Central

Received: 2019-01-14
Accepted: 2019-03-13
Published Online: 2019-04-15
Published in Print: 2019-07-26

©2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Preterm premature rupture of membranes (PPROM)
  4. Original Articles – Obstetrics
  5. The value of amniotic fluid analysis in patients with suspected clinical chorioamnionitis
  6. Patients with acute cervical insufficiency without intra-amniotic infection/inflammation treated with cerclage have a good prognosis
  7. Maternal serum endocan concentrations are elevated in patients with preterm premature rupture of membranes
  8. The earlier the gestational age, the greater the intensity of the intra-amniotic inflammatory response in women with preterm premature rupture of membranes and amniotic fluid infection by Ureaplasma species
  9. Assessment of maternal GBS colonization and early-onset neonatal disease rate for term deliveries: a decade perspective
  10. Clinical importance of the 75-g glucose tolerance test (GTT) in the prediction of large for gestational age (LGA) fetuses in non-diabetic pregnancies
  11. Expression of genes involved in inflammation and growth – does sampling site in human full-term placenta matter?
  12. Impact of cell-free fetal DNA on invasive prenatal diagnostic tests in a real-world public setting
  13. Perinatal outcome in gestational diabetes according to different diagnostic criteria
  14. Original Articles – Fetus
  15. Change in fetal behavior in response to vibroacoustic stimulation
  16. Diagnostic accuracy of isolated clubfoot in twin compared to singleton gestations
  17. Original Article – Newborn
  18. Usefulness of transcutaneous bilirubin assessment measured in non-photo-exposed skin to guide the length of phototherapy: an observational study
  19. Letters to the Editor
  20. Methodological issues on the clinical importance of the 75-g glucose tolerance test (GTT) in the prediction of large for gestational age (LGA) fetuses in non-diabetic pregnancies
  21. Reply to the Letter to the Editor: methodological issues on the clinical importance of the 75-g glucose tolerance test (GTT) in the prediction of large-for-gestational-age (LGA) fetuses in non-diabetic pregnancies
Downloaded on 26.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2019-0013/html
Scroll to top button